Philip Gerretsen
Philip Gerretsen
Centre for Addiction and Mental Health
Verified email at
Cited by
Cited by
Kynurenic acid in schizophrenia: a systematic review and meta-analysis
E Plitman, Y Iwata, F Caravaggio, S Nakajima, JK Chung, P Gerretsen, ...
Schizophrenia bulletin 43 (4), 764-777, 2017
Drugs with anticholinergic properties: a current perspective on use and safety
P Gerretsen, BG Pollock
Expert opinion on drug safety 10 (5), 751-765, 2011
The potential role of dopamine D3 receptor neurotransmission in cognition
S Nakajima, P Gerretsen, H Takeuchi, F Caravaggio, T Chow, B Le Foll, ...
European Neuropsychopharmacology 23 (8), 799-813, 2013
Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia
NE MacKenzie, C Kowalchuk, SM Agarwal, KA Costa-Dookhan, ...
Frontiers in psychiatry 9, 622, 2018
Glutamate-mediated excitotoxicity in schizophrenia: a review
E Plitman, S Nakajima, C de la Fuente-Sandoval, P Gerretsen, ...
European Neuropsychopharmacology 24 (10), 1591-1605, 2014
Individual determinants of COVID-19 vaccine hesitancy
P Gerretsen, J Kim, F Caravaggio, L Quilty, M Sanches, S Wells, ...
PloS one 16 (11), e0258462, 2021
Sequential drug treatment algorithm for agitation and aggression in Alzheimer˘s and mixed dementia
SJC Davies, AM Burhan, D Kim, P Gerretsen, A Graff-Guerrero, VL Woo, ...
Journal of Psychopharmacology 32 (5), 509-523, 2018
Glutamatergic neurometabolite levels in patients with ultra-treatment-resistant schizophrenia: a cross-sectional 3T proton magnetic resonance spectroscopy study
Y Iwata, S Nakajima, E Plitman, F Caravaggio, J Kim, P Shah, W Mar, ...
Biological psychiatry 85 (7), 596-605, 2019
Structural and functional alterations of the suicidal brain: an updated review of neuroimaging studies
A Bani-Fatemi, S Tasmim, A Graff-Guerrero, P Gerretsen, J Strauss, ...
Psychiatry Research: Neuroimaging 278, 77-91, 2018
Neuroimaging findings in treatment-resistant schizophrenia: a systematic review: lack of neuroimaging correlates of treatment-resistant schizophrenia
S Nakajima, H Takeuchi, E Plitman, G Fervaha, P Gerretsen, ...
Schizophrenia research 164 (1-3), 164-175, 2015
Insight and medication adherence in schizophrenia: An analysis of the CATIE trial
J Kim, M Ozzoude, S Nakajima, P Shah, F Caravaggio, Y Iwata, ...
Neuropharmacology 168, 107634, 2020
Evaluation of antipsychotic dose reduction in late-life schizophrenia: a prospective dopamine D2/3 receptor occupancy study
A Graff-Guerrero, TK Rajji, BH Mulsant, S Nakajima, F Caravaggio, ...
JAMA psychiatry 72 (9), 927-934, 2015
The effects of aging on insight into illness in schizophrenia: a review
P Gerretsen, E Plitman, TK Rajji, A Graff‐Guerrero
International journal of geriatric psychiatry 29 (11), 1145-1161, 2014
Impaired insight into illness and cognitive insight in schizophrenia spectrum disorders: resting state functional connectivity
P Gerretsen, M Menon, DC Mamo, G Fervaha, G Remington, BG Pollock, ...
Schizophrenia research 160 (1-3), 43-50, 2014
The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: a systematic review
P Shah, Y Iwata, E Plitman, EE Brown, F Caravaggio, J Kim, S Nakajima, ...
Psychiatry research 268, 114-122, 2018
Reduced Insulin Sensitivity Is Related to Less Endogenous Dopamine at D2/3 Receptors in the Ventral Striatum of Healthy Nonobese Humans
F Caravaggio, C Borlido, M Hahn, Z Feng, G Fervaha, P Gerretsen, ...
International Journal of Neuropsychopharmacology 18 (7), pyv014, 2015
Acute treatment of paediatric migraine: A meta‐analysis of efficacy
S Silver, D Gano, P Gerretsen
Journal of paediatrics and child health 44 (1‐2), 3-9, 2008
Exploring the neural correlates of delusions of reference
M Menon, TW Schmitz, AK Anderson, A Graff, M Korostil, D Mamo, ...
Biological psychiatry 70 (12), 1127-1133, 2011
Ventral striatum binding of a dopamine D2/3 receptor agonist but not antagonist predicts normal body mass index
F Caravaggio, S Raitsin, P Gerretsen, S Nakajima, A Wilson, ...
Biological psychiatry 77 (2), 196-202, 2015
Lifetime history of depression predicts increased amyloid-â accumulation in patients with mild cognitive impairment
JK Chung, E Plitman, S Nakajima, TW Chow, MM Chakravarty, ...
Journal of Alzheimer's Disease 45 (3), 907-919, 2015
The system can't perform the operation now. Try again later.
Articles 1–20